Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yinqiao Qingyan granule is a Traditional Chinese Medicine (TCM) hospital preparation developed by the Guangdong Secondary Hospital of Traditional Chinese Medicine. It is specifically formulated to treat respiratory conditions such as acute bronchitis and infections caused by the respiratory syncytial virus (RSV). The preparation is based on the classic Yinqiao San formula, which traditionally utilizes herbs like *Lonicera japonica* (Jin Yin Hua) and *Forsythia suspensa* (Lian Qiao) to clear heat and detoxify the body. Yinqiao Qingyan granule is designed to alleviate symptoms of wind-heat in the lungs, including sore throat, cough, and fever, by exerting antiviral and anti-inflammatory effects. It has been clinically utilized within the hospital's medical network for pediatric and adult respiratory care.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yinqiao Qingyan granule.